Suicidality associated with antidepressants and deadly psychiatry
The BMJ printed two excellent letters to the paper of Sharma et al. [1].Dubicka et al. [2] are absolutely right to be concerned about the editorial process (a poor research paper and an incorrect editorial comment) and the consequences to the public. Again: Depression in young people is underdiagnosed and undertreated. The complex problems are known ( poor qualitity of intransparent data, difficulties to interpret meta-analyses, influence of pharmaceutical industry etc.). The rapid response of Gøtzsche PC to the research paper of Sharma[1] shows the possible, fatal consequences. Gøtzsche wrote that “ researchers noted that the companies had underreported the suicide risk in their trials, and they also found that non-fatal self-harm and suicidality were seriously underreported compared to the reported suicides. There are many other reasons why the FDA seriously underreported suicides”. Gøtzsche concluded that it should be forbidden to use antidepressants in children and young People. I believe that such statements are no evidence based medicine or individualized treatments or balanced risk- benefit analysis. This is an one-dimensional, dangerous ideology [3].
1)Sharma et al. BMJ 2016;352:i65
2) Dubicka et al. BMJ 2016; 352 doi: http://dx.doi.org/10.1136/bmj.i911 (Published 16 February 2016)
3). Gøtzsche PC. Deadly psychiatry and organised denial. Copenhagen: People’s Press; 2015
Competing interests:
No competing interests
20 February 2016
Detlef Degner
psychiatrist
Department of Psychiatry and Psychotherapy, University of Göttingen, Germany
Rapid Response:
Suicidality associated with antidepressants and deadly psychiatry
The BMJ printed two excellent letters to the paper of Sharma et al. [1].Dubicka et al. [2] are absolutely right to be concerned about the editorial process (a poor research paper and an incorrect editorial comment) and the consequences to the public. Again: Depression in young people is underdiagnosed and undertreated. The complex problems are known ( poor qualitity of intransparent data, difficulties to interpret meta-analyses, influence of pharmaceutical industry etc.). The rapid response of Gøtzsche PC to the research paper of Sharma[1] shows the possible, fatal consequences. Gøtzsche wrote that “ researchers noted that the companies had underreported the suicide risk in their trials, and they also found that non-fatal self-harm and suicidality were seriously underreported compared to the reported suicides. There are many other reasons why the FDA seriously underreported suicides”. Gøtzsche concluded that it should be forbidden to use antidepressants in children and young People. I believe that such statements are no evidence based medicine or individualized treatments or balanced risk- benefit analysis. This is an one-dimensional, dangerous ideology [3].
1)Sharma et al. BMJ 2016;352:i65
2) Dubicka et al. BMJ 2016; 352 doi: http://dx.doi.org/10.1136/bmj.i911 (Published 16 February 2016)
3). Gøtzsche PC. Deadly psychiatry and organised denial. Copenhagen: People’s Press; 2015
Competing interests: No competing interests